Cannabis Science and Technology May 2022 Issue

Louisiana rings in the new year with new THC and CBD legislation for both the cannabis and hemp industries.

In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.

As we begin the year 2025, let’s review the most popular trends and topics in webinars covered by Cannabis Science and Technology in 2024.

Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.

Check out the complete series from our Cannabis Analysis column.

Here, Scott Mazza, Founder of Vitality CBD, discusses what science and law say about the cannabinoid THCA.